Smoking is associated with increased HbA1c values and microalbuminuria in patients with diabetes--data from the National Diabetes Register in Sweden

Diabetes & Metabolism
Peter M NilssonSteering Committee of the Swedish National Diabetes Register

Abstract

The aim was to examine trends in the proportion of smoking in diabetes patients, and to study associations between smoking, glycaemic control, and microalbuminuria. Smoking habits were reported to the Swedish National Diabetes Register (NDR), with data from hospitals and primary health care. Patient characteristics included were age, gender, type of treatment, diabetes duration, HbA1c, BMI, blood pressure, antihypertensive and lipid-lowering drugs, and microalbuminuria. The proportion of smokers in type 1 diabetes was 12-15% during 1996-2001, it was high in females<30 years (12-16%), and was higher in the age group 30-59 years (13-17%) than in older (6-9%) patients. The corresponding proportion of smoking in type 2 diabetes was 10-12%, higher in those less than 60 years of age (17-22%) than in older (7-9%) patients. Smoking type 1 and type 2 patients in 2001 had higher mean HbA1c but lower mean BMI values than non-smokers. Smokers also had higher frequencies of microalbuminuria, in both type 1 (18 vs 14%) and type 2 (20% vs 13%) diabetes. Multiple logistic regression analyses disclosed that smoking was independently associated with elevated HbA1c levels (p<0.001) and microalbuminuria (p<0.001), but negatively with BMI (p<0.001)...Continue Reading

References

Feb 1, 1990·Journal of Internal Medicine·B M LundmanA Norberg
Mar 4, 1995·BMJ : British Medical Journal·E B RimmW C Willett
Apr 17, 1998·Diabetic Medicine : a Journal of the British Diabetic Association·P M NilssonJ Sundquist
Aug 18, 2000·Journal of Internal Medicine·P G PerssonV Grill
Jun 21, 2001·International Journal of Epidemiology·L A SargeantN J Wareham
Aug 28, 2001·Diabetes Care·S G WannametheeUNKNOWN British Regional Heart Study
Oct 25, 2002·Journal of the American Society of Nephrology : JASN·Bruno BaggioPaola Fioretto
Feb 28, 2003·Clinical Science·Richard G IjzermanCoen D A Stehouwer
Mar 29, 2003·Diabetes Care·Soffia GudbjörnsdottirUNKNOWN Steering Committee of the Swedish National Diabetes Register
Apr 22, 2003·Progress in Cardiovascular Diseases·Björn Eliasson

❮ Previous
Next ❯

Citations

Aug 22, 2012·Endocrine·Trefor Higgins
Jun 10, 2006·Scandinavian Journal of Public Health. Supplement·Mats Eliasson, Gunnel Boström
Aug 13, 2010·Lipids in Health and Disease·Zeinab GhazanfariAli Montazeri
Feb 6, 2009·Current Medical Research and Opinion·G V GillS C Bain
Nov 26, 2015·Diabetes Research and Clinical Practice·Magnus Thorsten JensenJan Skov Jensen
Jul 16, 2015·European Journal of Clinical Nutrition·S N BalkUNKNOWN EURODIAB Prospective Complications Study Group
Mar 25, 2016·North American Journal of Medical Sciences·Satyajeet RoyJohn P Gaughan
Nov 29, 2011·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·P A GerberR Lehmann
Dec 17, 2015·Acta Diabetologica·Maija FeodoroffPer-Henrik Groop
Oct 8, 2011·Diabetic Medicine : a Journal of the British Diabetic Association·S PilacinskiB Wierusz-Wysocka
Mar 23, 2012·Diabetic Medicine : a Journal of the British Diabetic Association·S A DuffyUNKNOWN Veterans Integrated Service Network (VISN) 11 Tobacco Tactics Team
Sep 23, 2008·The Journal of Pediatrics·Sabine E HoferUNKNOWN DPV-Wiss. Study Group
Sep 24, 2005·Diabetic Medicine : a Journal of the British Diabetic Association·B EliassonUNKNOWN Steering Committee of the Swedish National Diabetes Register
Feb 16, 2006·Journal of Internal Medicine·M RidderstråleUNKNOWN Steering Committee of the Swedish National Diabetes Register (NDR)
Jan 8, 2009·Diabetic Medicine : a Journal of the British Diabetic Association·S GudbjörnsdottirUNKNOWN Swedish National Diabetes Register (NDR)
May 8, 2015·Journal of General Internal Medicine·Carole ClairNancy A Rigotti
Oct 24, 2013·Diabetes Research and Clinical Practice·Andrew M TomlinMurray W Tilyard
Jun 19, 2012·Clinical Biochemistry·Trefor Higgins
Apr 15, 2011·Metabolism: Clinical and Experimental·Christina VoulgariNicholas Tentolouris
Jun 2, 2012·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Peter ManuMarc De Hert
Nov 13, 2009·Diabetes Care·Peter M Nilsson, Karl-Olov Fagerström
Aug 30, 2016·Obesity·Terry BushKelly M Carpenter
Jan 31, 2008·Acta Clinica Belgica·B F Schrijvers, A S De Vriese
Feb 11, 2010·Journal of Diabetes Science and Technology·Trefor HigginsJulie Chan
Apr 20, 2010·Foot & Ankle Specialist·Robert M GreenhagenNicholas J Bevilacqua
May 12, 2009·Diabetes Research and Clinical Practice·Serena Tonstad
Jun 30, 2009·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Peter M NilssonUNKNOWN Swedish National Diabetes Register
Jan 1, 2013·Diabetes & Metabolism Journal·Sang Ah Chang
Nov 10, 2006·Diabetes/metabolism Research and Reviews·György Jermendy, Piero Ruggenenti
Apr 29, 2005·Diabetes/metabolism Research and Reviews
Nov 10, 2006·Journal of the American Society of Nephrology : JASN·Sharon J ElliotGary E Striker
Nov 5, 2005·Journal of Hypertension·Peter M NilssonUNKNOWN Steering Committee of the National Diabetes Register of Sweden

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.